FDA Drug recall D-0732-2022
TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi dose 10ML vial, as a) 5 ML Formula ID 115678
- FDA Drug
- Class II
- terminated
- Published 2022-04-06
On 2022-04-06 the FDA classified a Class II recall of TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi dose 10ML vial, as a) 5 ML Formula ID 115678 by Drug Depot, citing lack of sterility assurance.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0732-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2022-03-23 |
| Published | 2022-04-06 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Drug Depot |
| Distribution | US |
Product
TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi dose 10ML vial, as a) 5 ML Formula ID 115678; b) 10 ML Formula ID 115498, APS Pharmacy
Reason
Lack of sterility assurance.
Identifiers
| code_info | Lots: a)746000 BUD: 6/26/2022; b) 751472 BUD: 7/20/2022 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0732-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.